Skip to main content
Figure 3 | BMC Complementary and Alternative Medicine

Figure 3

From: The induction of activating transcription factor 3 (ATF3) contributes to anti-cancer activity of Abeliophyllum distichum Nakai in human colorectal cancer cells

Figure 3

Identification of ATF3 promoter sites responsible for EAFAD-B-induced ATF3 activation. (A, B) Each indicated constructs or (C, D) each deletion construct (0.5 μg) of the ATF3 promoter (0.5 μg) was co-transfected with 0.05 μg of pRL-null vector into HCT116 and SW480 cells, and cells were treated with 200 μg/ml of EAFAD-B. Luciferase activity was measured. *P < 0.05 compared to cells without EAFAD-B treatment.

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us